PHASE-II TRIAL OF TAXOL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

被引：46

作者：

EINZIG, AI

GOROWSKI, E

SASLOFF, J

WIERNIK, PH

机构：

[1] ALBERT EINSTEIN CANC CTR,BRONX,NY

[2] MONTEFIORE MED CTR,BRONX,NY 10467

来源：

CANCER INVESTIGATION | 1991年 / 9卷 / 02期

关键词：

D O I：

10.3109/07357909109044223

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

引用

页码：133 / 136

页数：4

共 17 条

[1] DONEHOWER RC, 1987, CANCER TREAT REP, V71, P1171
[2] GREM JL, 1987, CANCER TREAT REP, V71, P1179
[3] CURRENT STATUS OF THERAPY OF ADVANCED RENAL CARCINOMA
HRUSHESKY, WJ
MURPHY, GP
[J]. JOURNAL OF SURGICAL ONCOLOGY, 1977, 9 (03) : 277 - 288
[4] KRIS MG, 1986, CANCER TREAT REP, V70, P605
[5] PHASE-I STUDY OF TAXOL USING A 5-DAY INTERMITTENT SCHEDULE
LEGHA, SS
TENNEY, DM
KRAKOFF, IR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) : 762 - 766
[6] LONGNECKER SM, 1987, CANCER TREAT REP, V71, P53
[7] CURRENT THERAPY FOR RENAL-CELL CARCINOMA
MCDONALD, MW
[J]. JOURNAL OF UROLOGY, 1982, 127 (02) : 211 - 217
[8] OHNUMA T, 1985, P AM ASSOC CANC RES, V26, P167
[9] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
OKEN, MM
CREECH, RH
TORMEY, DC
HORTON, J
DAVIS, TE
MCFADDEN, ET
CARBONE, PP
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06): : 649 - 655
[10] PROMOTION OF MICROTUBULE ASSEMBLY INVITRO BY TAXOL
SCHIFF, PB
FANT, J
HORWITZ, SB
[J]. NATURE, 1979, 277 (5698) : 665 - 667

← 1 2 →